rs12688128 — IL1RAPL2 IL1RAPL2 Intron Variant

IL1RAPL2 — A Synaptic Gene on the X Chromosome with an Uncertain Role in Thyrotoxic Paralysis

IL1RAPL2¹¹ IL1RAPL2
interleukin-1 receptor accessory protein-like 2; gene ID 26280, located at Xq22.3 is a member of the IL-1 receptor superfamily expressed almost exclusively in the central nervous system. Unlike most IL-1 receptor family members that participate in immune signaling, IL1RAPL2 functions as a synaptic adhesion molecule²² synaptic adhesion molecule
a protein that bridges presynaptic and postsynaptic membranes to organize and stabilize connections between neurons — its primary job is building and maintaining connections between neurons, not immune regulation. The gene spans more than a megabase of the X chromosome (Xq22.3) and is closely related to IL1RAPL1, which is an established cause of X-linked cognitive disability and autism when deleted or mutated.

The rs12688128 variant is an intronic substitution (T→A) with no known functional consequence at the protein level. It appears in only one publication: a 2007 Thai study examining genetic susceptibility to thyrotoxic hypokalaemic periodic paralysis³³ thyrotoxic hypokalaemic periodic paralysis
THPP: episodic muscle weakness triggered by excess thyroid hormone, especially in hyperthyroid Asian men; thought to involve potassium shifts into muscle cells.

The Mechanism

IL1RAPL2 protein interacts trans-synaptically with PTPδ⁴⁴ PTPδ
protein tyrosine phosphatase delta, expressed on presynaptic axons; a synaptic organizer that pairs with postsynaptic proteins to specify synapse type and location on the presynaptic axon and with RhoGAP2 in the postsynaptic density. Together, this complex drives the formation of excitatory synapses and dendritic spines — the structural basis of learning and memory. Mouse studies show that Il1rapl2 is expressed in the nervous system from embryonic day 12.5 onward, consistent with a role in circuit assembly during early brain development.

The rs12688128 variant sits within an intron of IL1RAPL2, and no study has demonstrated that it alters splicing, expression, or protein function. Its CADD score of 0.376 and GERP score of −2.76 both indicate low evolutionary constraint and a low predicted functional impact — meaning this specific nucleotide position is not under strong purifying selection. The most plausible interpretation is that rs12688128 is a population-frequency marker in linkage disequilibrium with another variant elsewhere in the Xq22 region that might have functional relevance.

The Evidence

The single study linking rs12688128 to disease is Jongjaroenprasert et al. 2008⁵⁵ Jongjaroenprasert et al. 2008
"Association of genetic variants in GABRA3 gene and thyrotoxic hypokalaemic periodic paralysis in Thai population." Clin Endocrinol (Oxf) 68:646-51. This group used pooled DNA microarrays (50 THPP cases vs 50 hyperthyroid controls) and identified two SNPs — rs750841 and rs12688128 — that together formed a haplotype with a relative risk of 19 (P<0.0002) for THPP. The paper described both as "GABRA3 variants," but dbSNP places rs12688128 in the IL1RAPL2 intron at chrX:104,747,771, approximately 47 Mb centromeric from GABRA3 at chrX:152,297,246. Whether the original grouping reflects a genomic annotation error, linkage disequilibrium misclassification, or another explanation has not been clarified in subsequent literature.

Critically, this finding was not replicated in a Korean cohort⁶⁶ not replicated in a Korean cohort
Park et al. 2016, Endocrinol Metab (Seoul): 48 TPP cases vs 48 non-TPP Graves disease controls; GABRA3 polymorphisms showed OR 1.83, P=0.41 — not significant. The Korean study used a different population and different methodology, so the null result cannot definitively refute the Thai finding, but it means the association has failed its first replication attempt.

A separate reproductive biology connection comes from a 2025 bovine embryo study finding that IL1RAPL2 shows sex-biased differential exon usage in early blastocysts⁷⁷ sex-biased differential exon usage in early blastocysts
Shi et al. 2025, Cell Biosci: male and female bovine embryos activate IL1RAPL2 in sex-specific splice patterns as early as the blastocyst stage. This suggests the IL1RAPL2 locus participates in sex-specific transcriptional programs during early embryo development — relevant context for a variant on the X chromosome that is hemizygous in males and heterozygous in females.

Practical Actions

Because rs12688128 is an intronic variant with no known functional effect on IL1RAPL2 protein, and its only disease association (THPP) is based on a single small unreplicated study, clinical action at this locus is limited. Thyrotoxic hypokalaemic periodic paralysis occurs almost exclusively in the setting of hyperthyroidism (most commonly Graves disease) and resolves when thyroid function is normalized — making the genetic risk modifier of secondary importance compared to thyroid status itself.

For carriers of the A allele who are also hyperthyroid or have Graves disease, awareness that periodic paralysis episodes can occur — and can be severe enough to require emergency potassium supplementation — is the most actionable piece of information from this locus given current evidence.

Interactions

The Thai study identified rs12688128 in combination with rs750841 (an intronic GABRA3 variant). The combined haplotype showed a much larger association than either SNP alone (RR=19), suggesting potential epistatic or haplotype-level effects. GABRA3 encodes the alpha-3 subunit of the GABA-A receptor, which has documented roles in thyroid hormone sensitivity of skeletal muscle ion channels. If the association is genuine, the combination of rs750841 (GABRA3) and rs12688128 (IL1RAPL2) may tag a chromosomal haplotype whose functional variant has not yet been identified. The interaction should not be treated as established without replication.